Daiwa Securities Group Inc. - AGIOS PHARMACEUTICALS INC ownership

AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 191 filers reported holding AGIOS PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 3.93 and the average weighting 0.1%.

Quarter-by-quarter ownership
Daiwa Securities Group Inc. ownership history of AGIOS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$5
-16.7%
2040.0%0.00%
Q2 2023$6
+20.0%
2040.0%0.00%
Q1 2023$5
-16.7%
2040.0%0.00%
Q4 2022$6
-99.9%
2040.0%0.00%
Q3 2022$6,000
+20.0%
2040.0%0.00%
Q2 2022$5,0000.0%204
+29.1%
0.00%
Q1 2022$5,0000.0%1580.0%0.00%
Q4 2021$5,000
-44.4%
158
-21.8%
0.00%
Q3 2021$9,000
+28.6%
202
+65.6%
0.00%
Q2 2021$7,0000.0%122
-11.6%
0.00%
Q1 2021$7,000
+16.7%
138
+6.2%
0.00%
Q4 2020$6,000
-57.1%
130
-66.3%
0.00%
Q3 2020$14,0000.0%3860.0%0.00%
Q2 2020$14,0000.0%3860.0%0.00%
Q1 2020$14,000
-22.2%
3860.0%0.00%
Q4 2019$18,000
+50.0%
386
+4.0%
0.00%
Q3 2019$12,000
-36.8%
3710.0%0.00%
Q2 2019$19,000
-24.0%
3710.0%0.00%
Q1 2019$25,000
+78.6%
371
+18.2%
0.00%
Q4 2018$14,000
-41.7%
3140.0%0.00%
Q3 2018$24,000
-7.7%
3140.0%0.00%
Q2 2018$26,0000.0%3140.0%0.00%
Q1 2018$26,0003140.00%
Other shareholders
AGIOS PHARMACEUTICALS INC shareholders Q3 2019
NameSharesValueWeighting ↓
Flagship Ventures 2007 General Partner LLC 1,930,369$118,428,00083.56%
Third Rock Ventures, LLC 3,070,090$188,350,00021.97%
Opaleye Management Inc. 113,500$6,963,225,0005.43%
BB BIOTECH AG 1,890,521$115,983,0004.72%
Eventide Asset Management 431,600$26,479,0003.70%
Atika Capital Management LLC 54,000$3,313,0002.55%
Cormorant Asset Management, LP 100,000$6,135,0001.26%
BRIDGER MANAGEMENT, LLC 220,099$13,503,0000.92%
Ghost Tree Capital, LLC 20,000$1,227,0000.67%
HAMILTON LANE ADVISORS LLC 27,544$1,690,0000.55%
View complete list of AGIOS PHARMACEUTICALS INC shareholders